Norchim

France Updated 9 July 2026

Norchim is an API manufacturer based in France. Its GMP standing is certified by ANSM (FR). Its most recent recorded inspection, by US FDA, closed on 7 December 2022 as VAI.

active US DMFs

valid CEPs

registered plants 1 with an FDA FEI number

filings across 0 regulators

These figures were checked against the regulators' own files on 25 July 2026

Plants

1 of 1 confirmed

Inspections

2 of 2 confirmed

Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

7 December 2022 VAI US FDA
21 June 2012 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site	FDA FEI
SAINT LEU D'ESSERENT, France	Not on file
France, France	3002809489
SAINT LEU D'ESSERENT, France	Not on file
Saint-Leu-D'esserent, France	Not on file

What they file, and where

Molecule	Regulators	Docs
Acetylcholine	SFDA (Saudi Arabia)	1
Dexmedetomidine	SFDA (Saudi Arabia)	1

Also appears on these molecule pages

Dexmedetomidine API

Filings and GMP by regulator

Regulator	Filings	GMP certificates
ANSM (FR)	None	26

Scale

Year	Revenue	Exports	Destinations
2024	$19.0M	Not reported	Not reported

Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.

Comparing suppliers?

Choose your molecules and target markets. Norchim comes back tiered against every other supplier able to file there.

Start for free

No sales call.

Open risk flags

The most recent inspection outcome was VAI, on 7 December 2022.

Sources on this page

FDA: Drug master files, establishment registration, inspection classifications
EDQM: Certificates of suitability
EudraGMDP and national regulators: GMP certificates
Company filings: Revenue as reported